Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients

Title
Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 129, Issue 1, Pages 143-150
Publisher
Wiley
Online
2010-09-09
DOI
10.1002/ijc.25669

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now